Cargando…

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival

BACKGROUND: The independent prognostic role of squamous differentiation in pT1 bladder urothelial carcinoma has not been reported in previous studies. This article describes the impact of squamous differentiation on tumor recurrence and survival, and whether this histologic variant could indeed alte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Gang, Yu, Jianpeng, Song, Hualin, Zhu, Shimiao, Sun, Libin, Shang, Zhiqun, Niu, Yuanjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549361/ https://www.ncbi.nlm.nih.gov/pubmed/28789622 http://dx.doi.org/10.1186/s12885-017-3520-1

Ejemplares similares

Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer
por: Li, Gang, et al.
Publicado: (2016)

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
por: Li, Gang, et al.
Publicado: (2017)

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies
por: Zhu, Shimiao, et al.
Publicado: (2013)

High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients
por: Zhang, Zheng, et al.
Publicado: (2018)

Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression
por: Hu, Jieping, et al.
Publicado: (2018)

Mandibular Metastasis of a Recurrent Poorly Differentiated Urothelial Bladder Carcinoma
por: Aoun, Georges, et al.
Publicado: (2020)

RETRACTED ARTICLE: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
por: Zhang, Boya, et al.
Publicado: (2021)

Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
por: Zhang, Boya, et al.
Publicado: (2023)

LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
por: Shang, Zhiqun, et al.
Publicado: (2019)

KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells
por: Shen, Tianyu, et al.
Publicado: (2019)

AB007. Neurotensin derived from cancer stroma contributes to castration resistance via promoting neuroendocrine transdifferentiation
por: Zhu, Shimiao, et al.
Publicado: (2016)

Overexpression of SIRT1 in urothelial carcinoma of the urinary bladder is associated with local recurrence and poor survival
por: Al-Maghrabi, Jaudah A.
Publicado: (2019)

YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
por: Shen, Tianyu, et al.
Publicado: (2020)

AB188. Vasohibin-1 and microvessel density predict prognosis in clear cell renal cell carcinoma
por: Tian, Hao, et al.
Publicado: (2016)

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder
por: Minato, Akinori, et al.
Publicado: (2018)

Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis
por: Zhao, Guobin, et al.
Publicado: (2019)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma
por: Lockhart, Kathleen, et al.
Publicado: (2021)

A switch from CD44(+) cell to EMT cell drives the metastasis of prostate cancer
por: Shang, Zhiqun, et al.
Publicado: (2014)

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2022)

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2023)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

A Case of Urinary Bladder Urothelial Carcinoma with Squamous, Glandular, and Plasmacytoid Differentiation
por: Makise, Naohiro, et al.
Publicado: (2014)

Superficial Urothelial Cancer in the Prostatic Urethra
por: Kirkali, Ziya, et al.
Publicado: (2006)

Natural History, Recurrence, and Progression in Superficial Bladder Cancer
por: Sylvester, Richard J.
Publicado: (2006)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling
por: Yu, Jianpeng, et al.
Publicado: (2023)

AB125. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2015)

AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2016)

CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma
por: Givechian, Kevin B., et al.
Publicado: (2018)

Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer
por: Chen, Xuanrong, et al.
Publicado: (2021)

Recurrence of Urothelial Bladder Carcinoma in the Colon Presenting as Hematochezia
por: El Douaihy, Youssef, et al.
Publicado: (2016)

Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors
por: Gluck, G, et al.
Publicado: (2014)

Evaluation of the Expression of HER2 and c-KIT Proteins as Prognostic Markers in Superficial Bladder Urothelial Carcinoma
por: Abdou Hassan, Wael, et al.
Publicado: (2021)

HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2023)

Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation – a rare manifestation
por: Duwe, Gregor, et al.
Publicado: (2023)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

AB107. Impact of variant differentiation on survival of patients with urothelial carcinoma of the bladder treated with radical
por: Ge, Peng, et al.
Publicado: (2015)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
por: Wang, Tian-Wei, et al.
Publicado: (2019)

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7nomod8ri9d5tkb38qb3sqa9lf